Baby Girl, Cabilez .

HRN: 25-67-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/08/2025
01/15/2025
IV
35 Mg
OD
PCAP C
Waiting Final Action 
01/08/2025
AMPICILLIN 250MG (VIAL)
01/08/2025
01/15/2025
IV
115 Mg
Q6h
PCAP C
Waiting Final Action 
01/08/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/08/2025
01/15/2025
PO
0.5
Q8h
Oral Candidiasis
Waiting Final Action 
01/10/2025
CEFTRIAXONE 1G (VIAL)
01/10/2025
01/16/2025
IV
250
Q24
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: